Patent intelligence · WO
WO 2005037272
DERIVES DE BENZIMIDAZOLE ET LEUR APPLICATION COMME INHIBITEURS DE LA PEPTIDE-DEFORMYLASE
DERIVES DE BENZIMIDAZOLE ET LEUR APPLICATION COMME INHIBITEURS DE LA PEPTIDE-DEFORMYLASE
Patent details — WO 2005037272
- Jurisdiction
- WO
- Status
- expired
- Grant date
- Apr 28, 2005
- Expiration
- Apr 23, 2025
- Applicant
- ARPIDA AS [DK]
- CPC classes
- A61K 31/ 4184 A I, A61K31/4184, A61P 31/ 04 A I, A61P/3104
Quick answer
WO 2005037272 (DERIVES DE BENZIMIDAZOLE ET LEUR APPLICATION COMME INHIBITEURS DE LA PEPTIDE-DEFORMYLASE) is held by ARPIDA AS [DK]. Status: expired. Granted Apr 28, 2005. Expires Apr 23, 2025 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ARPIDA AS [DK]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 4184 A I, A61K31/4184, A61P 31/ 04 A I, A61P/3104, A61P/3300, A61P/3306
More from ARPIDA AS [DK]
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 2005037272?
WO 2005037272 (DERIVES DE BENZIMIDAZOLE ET LEUR APPLICATION COMME INHIBITEURS DE LA PEPTIDE-DEFORMYLASE) is held by ARPIDA AS [DK]. Status: expired. Granted Apr 28, 2005. Expires Apr 23, 2025 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns WO 2005037272?
ARPIDA AS [DK] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 4 pharmaceutical patents for this assignee.
When does WO 2005037272 expire?
Our index shows an expiration date of Apr 23, 2025 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.